European Institute of Science
Logotype for European Institute of Science

European Institute of Science (EURI) investor relations material

European Institute of Science has been delisted

European Institute of Science Q3 2024 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for European Institute of Science
Q3 2024 earnings summary23 Oct, 2024

Executive summary

  • Acquired apotek365.se, an e-commerce platform for self-tests, marking a strategic shift to "Euris 2.0" with expanded product range and market reach in human and veterinary diagnostics.

  • Q3 2024 sales increased by 147% compared to the same quarter last year, driven by the new e-commerce business and expanded distribution channels.

  • Focus on launching new products and expanding into additional geographic markets, leveraging proprietary test development.

Financial highlights

  • Net sales for Jan–Sep 2024 were 784 tSEK, up from 454 tSEK year-over-year; Q3 sales were 277 tSEK, up from 112 tSEK.

  • Gross profit for Jan–Sep 2024 was 446 tSEK (278 tSEK prior year); gross margin was 57% (61%).

  • Net result for Jan–Sep 2024 was -1,907 tSEK, an improvement from -2,040 tSEK year-over-year; Q3 net result was -633 tSEK, up from -701 tSEK.

  • Earnings per share for Jan–Sep 2024 were -4.21 SEK, compared to -5.88 SEK prior year.

  • Cash and cash equivalents at period end were 354 tSEK, down from 2,196 tSEK last year.

Outlook and guidance

  • Anticipates continued sales growth and market expansion, with new product launches in both human and veterinary diagnostics.

  • Expects increased revenue, more proprietary products, and further geographic expansion.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.
European Institute of Science
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions

European Institute of Science is a Swedish company engaged in biotechnology and diagnostics. It conducts research and development of diagnostic instruments and biochemical reagents used in clinical laboratories. The company also provides consultancy services related to biomedical technology and analytical systems. The company is headquartered in Lund, Sweden, and its shares are listed on the NGM.